| 8.85 0.11 (1.26%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.81 | 1-year : | 12.63 |
| Resists | First : | 9.25 | Second : | 10.81 |
| Pivot price | 8.38 |
|||
| Supports | First : | 8.15 | Second : | 7.48 |
| MAs | MA(5) : | 8.88 |
MA(20) : | 8.24 |
| MA(100) : | 7.5 |
MA(250) : | 6.71 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 78.1  |
D(3) : | 83.4 |
| RSI | RSI(14): 61.6 |
|||
| 52-week | High : | 9.36 | Low : | 4.13 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ GDRX ] has closed below upper band by 20.7%. Bollinger Bands are 11.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.91 - 8.95 | 8.95 - 8.99 |
| Low: | 8.56 - 8.61 | 8.61 - 8.65 |
| Close: | 8.78 - 8.85 | 8.85 - 8.92 |
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Thu, 25 Jul 2024
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Wed, 24 Jul 2024
GDRX (GoodRx Holdings) GF Value - GuruFocus.com
Sun, 21 Jul 2024
Jupiter Asset Management Ltd. Buys Shares of 99,605 GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Fri, 12 Jul 2024
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt - Simply Wall St
Thu, 11 Jul 2024
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call - Business Wire
Fri, 21 Jun 2024
Lost Money on GoodRx Holdings, Inc.(GDRX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 94 (M) |
| Shares Float | 79 (M) |
| Held by Insiders | 12.6 (%) |
| Held by Institutions | 67 (%) |
| Shares Short | 8,260 (K) |
| Shares Short P.Month | 7,590 (K) |
| EPS | -0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.67 |
| Profit Margin | -0.9 % |
| Operating Margin | 10.3 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | -0.9 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 8.08 |
| EBITDA (p.s.) | 0.81 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 149 (M) |
| Levered Free Cash Flow | 99 (M) |
| PE Ratio | -885.01 |
| PEG Ratio | 0.7 |
| Price to Book value | 5.26 |
| Price to Sales | 1.09 |
| Price to Cash Flow | 5.62 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|